Takara Bio Inc
TSE:4974

Watchlist Manager
Takara Bio Inc Logo
Takara Bio Inc
TSE:4974
Watchlist
Price: 1 086 JPY 3.13% Market Closed
Market Cap: 130.8B JPY
Have any thoughts about
Takara Bio Inc?
Write Note

Intrinsic Value

The intrinsic value of one Takara Bio Inc stock under the Base Case scenario is 990.53 JPY. Compared to the current market price of 1 086 JPY, Takara Bio Inc is Overvalued by 9%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
990.53 JPY
Overvaluation 9%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Takara Bio Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Takara Bio Inc cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Takara Bio Inc?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Takara Bio Inc

Provide an overview of the primary business activities
of Takara Bio Inc.

What unique competitive advantages
does Takara Bio Inc hold over its rivals?

What risks and challenges
does Takara Bio Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Takara Bio Inc.

Provide P/S
for Takara Bio Inc.

Provide P/E
for Takara Bio Inc.

Provide P/OCF
for Takara Bio Inc.

Provide P/FCFE
for Takara Bio Inc.

Provide P/B
for Takara Bio Inc.

Provide EV/S
for Takara Bio Inc.

Provide EV/GP
for Takara Bio Inc.

Provide EV/EBITDA
for Takara Bio Inc.

Provide EV/EBIT
for Takara Bio Inc.

Provide EV/OCF
for Takara Bio Inc.

Provide EV/FCFF
for Takara Bio Inc.

Provide EV/IC
for Takara Bio Inc.

Show me price targets
for Takara Bio Inc made by professional analysts.

What are the Revenue projections
for Takara Bio Inc?

How accurate were the past Revenue estimates
for Takara Bio Inc?

What are the Net Income projections
for Takara Bio Inc?

How accurate were the past Net Income estimates
for Takara Bio Inc?

What are the EPS projections
for Takara Bio Inc?

How accurate were the past EPS estimates
for Takara Bio Inc?

What are the EBIT projections
for Takara Bio Inc?

How accurate were the past EBIT estimates
for Takara Bio Inc?

Compare the revenue forecasts
for Takara Bio Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Takara Bio Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Takara Bio Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Takara Bio Inc compared to its peers.

Compare the P/E ratios
of Takara Bio Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Takara Bio Inc with its peers.

Analyze the financial leverage
of Takara Bio Inc compared to its main competitors.

Show all profitability ratios
for Takara Bio Inc.

Provide ROE
for Takara Bio Inc.

Provide ROA
for Takara Bio Inc.

Provide ROIC
for Takara Bio Inc.

Provide ROCE
for Takara Bio Inc.

Provide Gross Margin
for Takara Bio Inc.

Provide Operating Margin
for Takara Bio Inc.

Provide Net Margin
for Takara Bio Inc.

Provide FCF Margin
for Takara Bio Inc.

Show all solvency ratios
for Takara Bio Inc.

Provide D/E Ratio
for Takara Bio Inc.

Provide D/A Ratio
for Takara Bio Inc.

Provide Interest Coverage Ratio
for Takara Bio Inc.

Provide Altman Z-Score Ratio
for Takara Bio Inc.

Provide Quick Ratio
for Takara Bio Inc.

Provide Current Ratio
for Takara Bio Inc.

Provide Cash Ratio
for Takara Bio Inc.

What is the historical Revenue growth
over the last 5 years for Takara Bio Inc?

What is the historical Net Income growth
over the last 5 years for Takara Bio Inc?

What is the current Free Cash Flow
of Takara Bio Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Takara Bio Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Takara Bio Inc

Current Assets 61B
Cash & Short-Term Investments 38B
Receivables 7.4B
Other Current Assets 15.7B
Non-Current Assets 60.7B
PP&E 50.1B
Intangibles 8.3B
Other Non-Current Assets 2.4B
Current Liabilities 7.8B
Accounts Payable 1.6B
Accrued Liabilities 1.4B
Other Current Liabilities 4.8B
Non-Current Liabilities 2.7B
Other Non-Current Liabilities 2.7B
Efficiency

Earnings Waterfall
Takara Bio Inc

Revenue
42.8B JPY
Cost of Revenue
-18.1B JPY
Gross Profit
24.8B JPY
Operating Expenses
-24B JPY
Operating Income
739m JPY
Other Expenses
-625m JPY
Net Income
114m JPY

Free Cash Flow Analysis
Takara Bio Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Takara Bio Inc's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Operating Income
Positive 3-Year Average ROIC
Negative Free Cash Flow
51/100
Profitability
Score

Takara Bio Inc's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Takara Bio Inc's solvency score is 93/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
93/100
Solvency
Score

Takara Bio Inc's solvency score is 93/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Takara Bio Inc

Wall Street analysts forecast Takara Bio Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Takara Bio Inc is 1 581 JPY with a low forecast of 1 010 JPY and a high forecast of 1 995 JPY.

Lowest
Price Target
1 010 JPY
7% Downside
Average
Price Target
1 581 JPY
46% Upside
Highest
Price Target
1 995 JPY
84% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Takara Bio Inc?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Takara Bio Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Takara Bio Inc Logo
Takara Bio Inc

Country

Japan

Industry

Biotechnology

Market Cap

130.8B JPY

Dividend Yield

1.57%

Description

Takara Bio, Inc. engages in development and marketing of genetic engineering technologies. The company is headquartered in Kusatsu-Shi, Shiga-Ken and currently employs 1,539 full-time employees. The company went IPO on 2004-12-07. The firm operates in three business segments. Bioindustry Support segment provides reagents for research (genetic engineering reagents, cell engineering reagents, protein engineering reagents), scientific instruments, contract services and license fees for gene related patents to research institutes, such as universities and companies where biotechnology research and development are conducted. Gene Medicine segment provides gene therapy-related development and sale licensing fees and trial products as an application field of genetic engineering technology and cell engineering technology which is core technology cultivated in development of research reagents. Medical Food and Biotechnology segment provides health food and health food research and development services, license fees for health food related patents, as well as license fees for mushrooms.

Contact

SHIGA-KEN
Kusatsu-shi
7-4-38, Noji-Higashi
+81775656920.0
www.takara-bio.co.jp

IPO

2004-12-07

Employees

1 539

Officers

CEO, President & Representative Director
Mr. Koichi Nakao
CFO, Senior Executive Officer & Director
Dr. Yoh Hamaoka Ph.D.
Executive Officer, Deputy GM of Corporate Headquarters & GM of Public Relations and IR Department
Takuya Kakemi
Managing Executive Officer & Head of Sales Division
Akira Kodera
Executive Officer, Deputy GM of Corporate Headquarters & GM of Human Resources Department
Noritaka Nishiwaki
Senior Managing Director & Director
Mr. Tsuyoshi Miyamura
Show More
VP, Executive Officer & Director
Mr. Junichi Mineno Ph.D.
CMCO, Senior Executive Officer & Director
Mr. Katsuhiko Kusakabe
Head of Research and Development
Mr. Andrew Farmer Ph.d.
Managing Executive Officer & Head of SCM Division
Kyoko Nakajima
Show Less

See Also

Discover More
What is the Intrinsic Value of one Takara Bio Inc stock?

The intrinsic value of one Takara Bio Inc stock under the Base Case scenario is 990.53 JPY.

Is Takara Bio Inc stock undervalued or overvalued?

Compared to the current market price of 1 086 JPY, Takara Bio Inc is Overvalued by 9%.

Back to Top